Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia

Joel Morganroth, Frank V. Brozovich, John T. McDonald, Robert A. Jacobs

Research output: Contribution to journalArticle

163 Citations (Scopus)

Abstract

Torsades de pointes is the form of polymorphic ventricular tachycardia associated with prolongation of the QT interval that can occur as a proarrhythmic adverse response to a variety of drug treatments.1,2 However, the degree of QT prolongation at rest3,4 or during exercise5 is not necessarily a good predictor of the occurrence of torsades de pointes. Prolongation of the QT interval duration is seen during therapy with many different types of drugs including class IA antiarrhythmic agents as well as ketanserin, amiodarone, bepridil, sotalol, antidepressants, phenothiazines, erythromycin, antihistamines and liquid protein diets. Quinidine is the drug most frequently implicated in this syndrome with a calculated incidence of 1 to 8%.4 However, plasma drug level, absolute QT interval prolongation and the absolute QTC have not been found to be very good predictors of the development of torsades de pointes.3,4. Data on the spontaneous variability of the QT interval over time in normal subjects have not been established. Thus, we determined the magnitude of spontaneous QT interval variability over just 1 day using ambulatory long-term electrocardiographic (Holter) monitoring. Knowledge of normal variability of the QT interval is important in that prolongation of the QT interval during drug therapy is considered to be a risk factor for the development of a potential proarrhythmic effect. However, knowledge of the daily spontaneous variability of the QT interval makes it possible to determine the magnitude of QT interval prolongation, which is clinically important with respect to its potential as a marker for risk of proarrhythmia.

Original languageEnglish (US)
Pages (from-to)774-776
Number of pages3
JournalThe American Journal of Cardiology
Volume67
Issue number8
DOIs
StatePublished - Apr 1 1991
Externally publishedYes

Fingerprint

Drug-Related Side Effects and Adverse Reactions
Torsades de Pointes
Pharmaceutical Preparations
Bepridil
Phenothiazines
Sotalol
Ketanserin
Ambulatory Electrocardiography
Quinidine
Amiodarone
Histamine Antagonists
Erythromycin
Ventricular Tachycardia
Antidepressive Agents
Diet
Drug Therapy
Incidence
Proteins
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia. / Morganroth, Joel; Brozovich, Frank V.; McDonald, John T.; Jacobs, Robert A.

In: The American Journal of Cardiology, Vol. 67, No. 8, 01.04.1991, p. 774-776.

Research output: Contribution to journalArticle

Morganroth, Joel ; Brozovich, Frank V. ; McDonald, John T. ; Jacobs, Robert A. / Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia. In: The American Journal of Cardiology. 1991 ; Vol. 67, No. 8. pp. 774-776.
@article{7e15f5236e154085b4d3e29ef24ea034,
title = "Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia",
abstract = "Torsades de pointes is the form of polymorphic ventricular tachycardia associated with prolongation of the QT interval that can occur as a proarrhythmic adverse response to a variety of drug treatments.1,2 However, the degree of QT prolongation at rest3,4 or during exercise5 is not necessarily a good predictor of the occurrence of torsades de pointes. Prolongation of the QT interval duration is seen during therapy with many different types of drugs including class IA antiarrhythmic agents as well as ketanserin, amiodarone, bepridil, sotalol, antidepressants, phenothiazines, erythromycin, antihistamines and liquid protein diets. Quinidine is the drug most frequently implicated in this syndrome with a calculated incidence of 1 to 8{\%}.4 However, plasma drug level, absolute QT interval prolongation and the absolute QTC have not been found to be very good predictors of the development of torsades de pointes.3,4. Data on the spontaneous variability of the QT interval over time in normal subjects have not been established. Thus, we determined the magnitude of spontaneous QT interval variability over just 1 day using ambulatory long-term electrocardiographic (Holter) monitoring. Knowledge of normal variability of the QT interval is important in that prolongation of the QT interval during drug therapy is considered to be a risk factor for the development of a potential proarrhythmic effect. However, knowledge of the daily spontaneous variability of the QT interval makes it possible to determine the magnitude of QT interval prolongation, which is clinically important with respect to its potential as a marker for risk of proarrhythmia.",
author = "Joel Morganroth and Brozovich, {Frank V.} and McDonald, {John T.} and Jacobs, {Robert A.}",
year = "1991",
month = "4",
day = "1",
doi = "10.1016/0002-9149(91)90541-R",
language = "English (US)",
volume = "67",
pages = "774--776",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia

AU - Morganroth, Joel

AU - Brozovich, Frank V.

AU - McDonald, John T.

AU - Jacobs, Robert A.

PY - 1991/4/1

Y1 - 1991/4/1

N2 - Torsades de pointes is the form of polymorphic ventricular tachycardia associated with prolongation of the QT interval that can occur as a proarrhythmic adverse response to a variety of drug treatments.1,2 However, the degree of QT prolongation at rest3,4 or during exercise5 is not necessarily a good predictor of the occurrence of torsades de pointes. Prolongation of the QT interval duration is seen during therapy with many different types of drugs including class IA antiarrhythmic agents as well as ketanserin, amiodarone, bepridil, sotalol, antidepressants, phenothiazines, erythromycin, antihistamines and liquid protein diets. Quinidine is the drug most frequently implicated in this syndrome with a calculated incidence of 1 to 8%.4 However, plasma drug level, absolute QT interval prolongation and the absolute QTC have not been found to be very good predictors of the development of torsades de pointes.3,4. Data on the spontaneous variability of the QT interval over time in normal subjects have not been established. Thus, we determined the magnitude of spontaneous QT interval variability over just 1 day using ambulatory long-term electrocardiographic (Holter) monitoring. Knowledge of normal variability of the QT interval is important in that prolongation of the QT interval during drug therapy is considered to be a risk factor for the development of a potential proarrhythmic effect. However, knowledge of the daily spontaneous variability of the QT interval makes it possible to determine the magnitude of QT interval prolongation, which is clinically important with respect to its potential as a marker for risk of proarrhythmia.

AB - Torsades de pointes is the form of polymorphic ventricular tachycardia associated with prolongation of the QT interval that can occur as a proarrhythmic adverse response to a variety of drug treatments.1,2 However, the degree of QT prolongation at rest3,4 or during exercise5 is not necessarily a good predictor of the occurrence of torsades de pointes. Prolongation of the QT interval duration is seen during therapy with many different types of drugs including class IA antiarrhythmic agents as well as ketanserin, amiodarone, bepridil, sotalol, antidepressants, phenothiazines, erythromycin, antihistamines and liquid protein diets. Quinidine is the drug most frequently implicated in this syndrome with a calculated incidence of 1 to 8%.4 However, plasma drug level, absolute QT interval prolongation and the absolute QTC have not been found to be very good predictors of the development of torsades de pointes.3,4. Data on the spontaneous variability of the QT interval over time in normal subjects have not been established. Thus, we determined the magnitude of spontaneous QT interval variability over just 1 day using ambulatory long-term electrocardiographic (Holter) monitoring. Knowledge of normal variability of the QT interval is important in that prolongation of the QT interval during drug therapy is considered to be a risk factor for the development of a potential proarrhythmic effect. However, knowledge of the daily spontaneous variability of the QT interval makes it possible to determine the magnitude of QT interval prolongation, which is clinically important with respect to its potential as a marker for risk of proarrhythmia.

UR - http://www.scopus.com/inward/record.url?scp=0025825919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025825919&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(91)90541-R

DO - 10.1016/0002-9149(91)90541-R

M3 - Article

VL - 67

SP - 774

EP - 776

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 8

ER -